Abstract:

Background: Prostate cancer (PC) is the second frequent cancer in men after lung cancer and it accounts for 3.8% of all deaths caused by cancer in men worldwide. This study aimed to determine the prevalence and management of prostate cancer among male patients admitted with cancer at Oncology Department of Bugando Medical Centre.

Methodology: This was a hospital based retrospective cross section study that retrieved 384 medical files of male patients admitted with cancer in Oncology wards at Bugando Medical Centre from January 2017 to December 2020.

Results: A total of 384 medical files of males with cancer were reviewed. The prevalence of prostate cancer was 39.84% (153 of 344 male patients) and prostate cancer was common in the age group of above 60 years old. The mean age of patients with prostate cancer was 64.85 years (Standard Deviation 14.59 years). Two thirds of the patients’ prostate cancer was graded at presentation. Of these, 49.46% (46 of 93 male patients whose prostate cancer was graded at presentation) were having a high grade prostate cancer of Gleason scores 8, 9 or 10. Prostate cancer chemotherapy involved goserelin (33.11%), bicalutamide (3.31%), docetaxel (1.99%) or combinations of these.

Conclusion: This study has shown a high prevalence of prostate cancer among male patients admitted with cancer at Oncology department of Bugando Medical Centre, which was common in older ages. Frequent screening and awareness programs among men should be done so as to early detect prostate cancer cases and reduce its morbidity and mortality.